Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gervois

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapyGiulia Fregni, Aurélie Perier, Gianfranco Pittari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cellsN Gervois, N Labarriere, S Le Guiner, et al.
Cancer Research|December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical EfficacySylvain Simon, Virginie Vignard, Emilie Varey, et al.
Chemical Biology & Drug Design|December 11, 2012
Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR featuresNicolas Renault, Xavier Laurent, Amaury Farce, et al.
European Journal of Immunology|March 4, 1998
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesE Le Dréan, F Vély, L Olcese, et al.
Blood|April 27, 1999
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alphaM Kockx, P P Gervois, P Poulain, et al.
Scientific Reports|August 27, 2021
A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screeningJuliette Vaurs, Gaël Douchin, Klara Echasserieau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
The Journal of Biological Chemistry|June 22, 2001
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein betaP Gervois, N Vu-Dac, R Kleemann, et al.
The Journal of Clinical Investigation|August 6, 1998
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoidsN Vu-Dac, P Gervois, I P Torra, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapyGiulia Fregni, Aurélie Perier, Gianfranco Pittari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cellsN Gervois, N Labarriere, S Le Guiner, et al.
Cancer Research|December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical EfficacySylvain Simon, Virginie Vignard, Emilie Varey, et al.
Chemical Biology & Drug Design|December 11, 2012
Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR featuresNicolas Renault, Xavier Laurent, Amaury Farce, et al.
European Journal of Immunology|March 4, 1998
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesE Le Dréan, F Vély, L Olcese, et al.
Blood|April 27, 1999
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alphaM Kockx, P P Gervois, P Poulain, et al.
Scientific Reports|August 27, 2021
A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screeningJuliette Vaurs, Gaël Douchin, Klara Echasserieau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
The Journal of Biological Chemistry|June 22, 2001
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein betaP Gervois, N Vu-Dac, R Kleemann, et al.
The Journal of Clinical Investigation|August 6, 1998
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoidsN Vu-Dac, P Gervois, I P Torra, et al.
Pageof 13